Indications
- Chronic Obstructive Pulmonary Disease (COPD) (see Chronic Obstructive Pulmonary Disease, [[Chronic Obstructive Pulmonary Disease]]
Pharmacology
- Long-Acting Anticholinergic-Muscarinic Receptor Antagonist (LAMA) (see Muscarinic Antagonists, [[Muscarinic Antagonists]])
- Bronchodilation
Metabolism
- xxx
Administration
- INH: 1 cap qday
Dose Adjustment
- Hepatic
- Renal
Adverse Effects
Pulmonary Adverse Effects
- xxx
- xxx
Other Adverse Effects
- xxx
- xxx
References
- xxx